Learning From The Lazarus Effect
Most clinical trials for cancer drugs are failures. But for a handful of patients, a drug roves to be nearly a cure. What can science learn from these “exceptional responders”?
May 13, 2016 at 04:00PM
via Digg http://ift.tt/1s1wUCz
No comments:
Post a Comment